David J. Mauro, Chief Medical Officer at Prelude Therapeutics Inc (PRLD), sold 22,466 shares at $39.69 ($886K) on 2021-04-07, disclosed to the SEC on 2021-04-09.
Open-market sale of $886k PRLD by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.03 | 8,300 | $324K | 36.6% |
| 2 | $39.69 | 7,083 | $281K | 31.7% |
| 3 | $39.69 | 7,083 | $281K | 31.7% |
| Total | $39.45 avg | 22,466 | $886K | 100% |
| Filing → |
| PRLD | SELL | 2021-08-09 | $930K | — | Filing → |
| PRLD | SELL | 2021-07-08 | $816K | — | Filing → |
| PRLD | SELL | 2021-06-09 | $902K | — | Filing → |